Ibrahim D. Bori

Array ( [id] => 11588420 [patent_doc_number] => 20170112831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-27 [patent_title] => 'USE OF CCR1 ANTAGONISTS AS A TREATMENT FOR TUMORS OF THE CENTRAL NERVOUS SYSTEM' [patent_app_type] => utility [patent_app_number] => 15/299701 [patent_app_country] => US [patent_app_date] => 2016-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9997 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11434864 [patent_doc_number] => 20170035885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-09 [patent_title] => 'HIGHLY CONCENTRATED STABLE MELOXICAM SOLUTIONS' [patent_app_type] => utility [patent_app_number] => 15/297594 [patent_app_country] => US [patent_app_date] => 2016-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3235 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15297594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11567293 [patent_doc_number] => 20170105937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'OLAPARIB CO-PRECIPITATE AND PREPARATION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 15/295235 [patent_app_country] => US [patent_app_date] => 2016-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3247 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13287603 [patent_doc_number] => 10154974 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-12-18 [patent_title] => Use of abscisic acid for the prevention and treatment of malaria [patent_app_type] => utility [patent_app_number] => 15/294630 [patent_app_country] => US [patent_app_date] => 2016-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 71 [patent_no_of_words] => 10278 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15294630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11401656 [patent_doc_number] => 20170022194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'STABLE CRYSTALLINE NORIBOGAINE SALT ANSOLVATES' [patent_app_type] => utility [patent_app_number] => 15/288945 [patent_app_country] => US [patent_app_date] => 2016-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6290 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11401655 [patent_doc_number] => 20170022193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'NORIBOGAINE SALT TABLETS' [patent_app_type] => utility [patent_app_number] => 15/288931 [patent_app_country] => US [patent_app_date] => 2016-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6289 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11555149 [patent_doc_number] => 20170101395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-13 [patent_title] => 'PYRIMIDINE DERIVATIVES AS CFTR MODULATORS' [patent_app_type] => utility [patent_app_number] => 15/287542 [patent_app_country] => US [patent_app_date] => 2016-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14324 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15287542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13457709 [patent_doc_number] => 20180280397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => RATIONAL COMBINATION THERAPY FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 15/765980 [patent_app_country] => US [patent_app_date] => 2016-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27975 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15765980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13440533 [patent_doc_number] => 20180271809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => USE OF NICLOSAMIDE IN THE TREATMENT OF P53-DEFICIENT CELLS [patent_app_type] => utility [patent_app_number] => 15/761081 [patent_app_country] => US [patent_app_date] => 2016-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14282 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15761081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12217428 [patent_doc_number] => 20180055787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-01 [patent_title] => 'CURCUMIN INFUSED MILK BEVERAGE AND A PROCESS FOR THE PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 15/252919 [patent_app_country] => US [patent_app_date] => 2016-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4209 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15252919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13386405 [patent_doc_number] => 20180244744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => A PROCESS FOR OBTAINING INSULIN WITH CORRECTLY FORMED DISULFIDE BONDS [patent_app_type] => utility [patent_app_number] => 15/755354 [patent_app_country] => US [patent_app_date] => 2016-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10860 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11469561 [patent_doc_number] => 20170056344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'METHODS OF TREATING LENNOX-GASTAUT SYNDROME USING FENFLURAMINE' [patent_app_type] => utility [patent_app_number] => 15/246346 [patent_app_country] => US [patent_app_date] => 2016-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9166 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15246346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11704554 [patent_doc_number] => 20170173053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'Method of Modulating Protein 14-3-3 Functionality By Facilitating or Inhibiting Phosphorylation' [patent_app_type] => utility [patent_app_number] => 15/237548 [patent_app_country] => US [patent_app_date] => 2016-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23544 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15237548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11121884 [patent_doc_number] => 20160318857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'N,N\'-Diarylurea Compounds and N,N\'-Diarylthiourea Compounds as Inhibitors of Translation Initiation' [patent_app_type] => utility [patent_app_number] => 15/216057 [patent_app_country] => US [patent_app_date] => 2016-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 25524 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15216057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11419827 [patent_doc_number] => 20170027971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'USE OF HDAC AND/OR DNMT INHIBITORS FOR TREATMENT OF ISCHEMIC INJURY' [patent_app_type] => utility [patent_app_number] => 15/213190 [patent_app_country] => US [patent_app_date] => 2016-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8016 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15213190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19593115 [patent_doc_number] => 12150933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-26 [patent_title] => IL-8 inihibitors for use in the treatment of some urological disorders [patent_app_type] => utility [patent_app_number] => 15/743721 [patent_app_country] => US [patent_app_date] => 2016-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 7781 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15743721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13777891 [patent_doc_number] => 20190002484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE [patent_app_type] => utility [patent_app_number] => 15/735885 [patent_app_country] => US [patent_app_date] => 2016-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31095 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -64 [patent_words_short_claim] => 464 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15735885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16168132 [patent_doc_number] => 10709671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-14 [patent_title] => Use of cannabinoids in the treatment of epilepsy [patent_app_type] => utility [patent_app_number] => 15/183947 [patent_app_country] => US [patent_app_date] => 2016-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6435 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15183947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11335568 [patent_doc_number] => 20160361322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-15 [patent_title] => 'COMPOSITION AND METHOD FOR ORAL DELIVERY OF ANDROGEN PRODRUGS' [patent_app_type] => utility [patent_app_number] => 15/183691 [patent_app_country] => US [patent_app_date] => 2016-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15968 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15183691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13647851 [patent_doc_number] => 09850230 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-26 [patent_title] => Compounds and compositions as protein kinase inhibitors [patent_app_type] => utility [patent_app_number] => 15/179644 [patent_app_country] => US [patent_app_date] => 2016-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21321 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15179644 [rel_patent_id] =>[rel_patent_doc_number] =>)